Morning Overview on MSN
Medical cannabis did little or nothing for sleep in a review of nine trials
A Cochrane review pooled nine trials of regulated medical cannabis for insomnia, covering 537 adults aged 18 to 76, and found ...
Zero HIV Acquisitions Occurred Among Participants Receiving Twice-Yearly Lenacapavir During the 52-Week Study Period – – ...
Could your handwriting offer clues into how your brain is aging?
Patients on Vafseo® (vadadustat) increased to approximately 11,500 at the end of Q3 2026 representing an increase of approximately 140% from the ...
Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced topline results from VOCAL, an ...
A major new review challenges the growing enthusiasm for medical cannabis as an insomnia treatment, finding little reliable ...
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, ...
Australians could soon be able to take one of the world’s most popular weight-loss medications in tablet form, following a ...
11don MSN
Americans Are Feeling Better About The Economy, But Many Are Still Worried About Finding Jobs.
The Conference Board's October confidence index rose to 91.7, but expectations for the next six months remained subdued.
This article contains promotionsA kids' camera is a small digital camera designed for children that allows them to take their ...
The 'bizarre festival of the soccer world'.This power word is something you are bound to hear around autumn in the amateur ...
Everyday Health on MSN
Is It Safe to Microdose Ozempic and Other GLP-1 Drugs?
People taking GLP-1 drugs like Ozempic are using microdosing and following click charts to manage side effects and costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results